EFFECTOR THERAPUTCS INC (EFTR) analyst actions
Rating and price-target actions on EFTR in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the EFTR overview →
1 measured EFTR analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| eFFECTOR Therapeutics to Collaborate with the Northwestern University Division of Hematology and Oncology on an Investigator-Initiated Phase 1 Dose Escalation Trial Evaluating Tomivosertib in Patients with Acute Myeloid Leukemia | Press release | +1.61% | +1.79% |
Keep exploring
More EFTR: earnings → · SEC filings → · EFTR overview →